Yesterday, Sunday, in Algiers, the Algerian bioequivalence center “Equival Biocenter” presented its first bioequivalence study to demonstrate the therapeutic efficacy of a generic antibiotic produced by the state-owned pharmaceutical group “Saidal”. Read more…

4th edition of the Intra-African Trade Fair – Pharmaceutical industry: partnerships worth 400 million dollars planned
The ambition is to build a “genuine” African pharmaceutical industry, “capable of ensuring” the continent’s health sovereignty and giving it “greater weight” on the world




